High-performance liquid chromatographic assay of 5-fluorouracil in human erythrocytes, plasma and whole blood.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Chromatography B: Biomedical Sciences and Applications

• Publication date

  1997-04-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0378-4347(96)00485-9PMID 9187406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients

  2004cited by this paper
• Calculation of Individual Dosage Regimen of Cytosine Arabinoside (Ara‐C) Based on Metabolite Levels in Leukemic Cells

  1994cited by this paper
• Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.

  1994cited by this paper
• Analysis of 5-fluorouracil in plasma and urine by high-performance liquid chromatography.

  1992cited by this paper
• Clinical Pharmacology of 5-Fluorouracil

  1989cited by this paper
• Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma.

  1985cited by this paper
• An Introduction to Pharmacokinetics

  1981cited by this paper

• Simple Quantitation of Flucytosine in Low Volume Serum Samples and Evaluation of Common Endogenous Interferences by HPLC-UV

  2022cites this paper
• Analytical method development and validation of anticancer agent, 5-fluorouracil, and its metabolites in biological matrices: An updated review

  2020cites this paper
• Development and Validation of a New Stability Indicating Reversed-phase High‑Performance Liquid Chromatography Method for the Simultaneous Estimation of Tegafur and Uracil in Capsule Dosage Form

  2018cites this paper
• RP-HPLC estimation of Capecitabine in pure and pharmaceutical dosage form

  2016cites this paper
• A SIMPLE AND RAPID METHOD FOR SIMULTANEOUS QUANTIFICATION OF DOXORUBICIN, EPIRUBICIN, CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL IN HUMAN PLASMA BY LCMS/MS

  2016cites this paper
• Development and optimization of fast and new reversed-phase HPLC method for analysis of 5-fluorouracil in human and rabbit plasma.

  2015cites this paper
• DEVELOPMENT AND VALIDATION OF A REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE ESTIMATION OF CYCLOPHOSPHAMIDE IN BULK DRUG

  2013cites this paper
• A fast and simple HPLC-UV method for simultaneous determination of three anti-cancer agents in plasma of breast cancer patients and its application to clinical pharmacokinetics

  2011cites this paper
• A review of analytical methods for the determination of 5-fluorouracil in biological matrices

  2010cites this paper
• Synthesis and Characterization of New Liver Targeting 5‐Fluorouracil‐Cholic Acid Conjugates

  2009cites this paper
• Improved determination of 5-fluorouracil and its prodrug tegafur in pharmaceuticals by large-volume sample stacking in CE.

  2007cites this paper
• 31P NMR Spectroscopy and Polarographic Combined Study of Erythrocytes Treated with 5‐Fluorouracil: Cardiotoxicity‐Related Changes in ATP, 2,3‐BPG, and O2 Metabolism

  2005cites this paper
• Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues.

  2005cites this paper
• Effects of 5-Fluorouracil on Erythrocytes in Relation to Its Cardiotoxicity: Membrane Structure and Functioning

  2005cites this paper
• Extraction sur phase solide et analyses par HPLC du 5-fluoro-uracile plasmatique

  2005cites this paper
• A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid

  2004cites this paper
• Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection.

  2004cites this paper
• Human Red Blood Cells: Rheological Aspects, Uptake, and Release of Cytotoxic Drugs

  2004cites this paper
• Determination of 5-Fluorouracil and Its Prodrug Tegafur in Plasma and Tissue by High-Performance Liquid Chromatography in a Single Injection: Validation for Application in Clinical Pharmacokinetic Studies

  2003cites this paper
• Rapid determination of 5-fluorouracil in plasma using capillary electrophoresis.

  2003cites this paper
• Role of Red Blood Cells in Pharmacokinetics of Chemotherapeutic Agents

  2003cites this paper
• Simultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients.

  2002cites this paper
• Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography.

  2001cites this paper
• Simple and sensitive determination of 5-fluorouracil in plasma by high-performance liquid chromatography. Application to clinical pharmacokinetic studies.

  1999cites this paper
• Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatography.

  1999cites this paper
• Role of red blood cells in pharmacokinetics of chemotherapeutic agents.

  1999cites this paper
• Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.

  1999cites this paper
• Comparison of 5‐Fluorouracil Pharmacokinetics in Whole Blood, Plasma, and Red Blood Cells in Patients with Colorectal Cancer

  1997cites this paper